Terms: = Leukemia AND CBFA2T3, ETO2, 863, ENSG00000129993, ZMYND4, MTGR2, MTG16
166 results:
1. Clinical Analysis of Pediatric Acute Megakaryocytic leukemia With cbfa2t3-GLIS2 Fusion Gene.
Du Y; Yang L; Qi S; Chen Z; Sun M; Wu M; Wu B; Tao F; Xiong H
J Pediatr Hematol Oncol; 2024 Mar; 46(2):96-103. PubMed ID: 38315896
[TBL] [Abstract] [Full Text] [Related]
2. Panel-based RNA fusion sequencing improves diagnostics of pediatric acute myeloid leukemia.
Hoffmeister LM; Suttorp J; Walter C; Antoniou E; Behrens YL; Göhring G; Awada A; von Neuhoff N; Reinhardt D; Schneider M
Leukemia; 2024 Mar; 38(3):538-544. PubMed ID: 38086945
[TBL] [Abstract] [Full Text] [Related]
3. cbfa2t3::GLIS2 pediatric acute megakaryoblastic leukemia is sensitive to BCL-XL inhibition by navitoclax and DT2216.
Gress V; Roussy M; Boulianne L; Bilodeau M; Cardin S; El-Hachem N; Lisi V; Khakipoor B; Rouette A; Farah A; Théret L; Aubert L; Fatima F; Audemard É; Thibault P; Bonneil É; Chagraoui J; Laramée L; Gendron P; Jouan L; Jammali S; Paré B; Simpson SM; Tran TH; Duval M; Teira P; Bittencourt H; Santiago R; Barabé F; Sauvageau G; Smith MA; Hébert J; Roux PP; Gruber TA; Lavallée VP; Wilhelm BT; Cellot S
Blood Adv; 2024 Jan; 8(1):112-129. PubMed ID: 37729615
[TBL] [Abstract] [Full Text] [Related]
4. cbfa2t3-GLIS2-dependent pediatric acute megakaryoblastic leukemia is driven by GLIS2 and sensitive to navitoclax.
Neault M; Lebert-Ghali CÉ; Fournier M; Capdevielle C; Garfinkle EAR; Obermayer A; Cotton A; Boulay K; Sawchyn C; St-Amand S; Nguyen KH; Assaf B; Mercier FE; Delisle JS; Drobetsky EA; Hulea L; Shaw TI; Zuber J; Gruber TA; Melichar HJ; Mallette FA
Cell Rep; 2023 Sep; 42(9):113084. PubMed ID: 37716355
[TBL] [Abstract] [Full Text] [Related]
5. Dynamics of polyclonal immuno-reconstitution after allogeneic transplant with post-transplant cyclophosphamide and letermovir.
Orofino G; Xue E; Doglio M; Noviello M; Tassi E; Cristante M; Acerbis A; Clerici D; Farina F; Campodonico E; Bruno A; Piemontese S; Mastaglio S; Diral E; Milani R; Ruggeri A; Corti C; Vago L; Bonini C; Peccatori J; Ciceri F; Lupo Stanghellini MT; Greco R
Bone Marrow Transplant; 2023 Oct; 58(10):1104-1111. PubMed ID: 37468541
[TBL] [Abstract] [Full Text] [Related]
6. Cancer Statistics in Pakistan From 1994 to 2021: Data From Cancer Registry.
Tufail M; Wu C
JCO Clin Cancer Inform; 2023 Jul; 7():e2200142. PubMed ID: 37450777
[TBL] [Abstract] [Full Text] [Related]
7. Acute myeloid leukemia with RAM immunophenotype: A new underdiagnosed entity.
Gajendra S; Anupurba S; Gupta R; Mallick S; Panda D; Thakral D; Gupta SK; Bakhshi S; Seth R; Rai S; Prajapati VK; Singh S
Int J Lab Hematol; 2023 Aug; 45(4):541-552. PubMed ID: 37078511
[TBL] [Abstract] [Full Text] [Related]
8. Etiology of oncogenic fusions in 5,190 childhood cancers and its clinical and therapeutic implication.
Liu Y; Klein J; Bajpai R; Dong L; Tran Q; Kolekar P; Smith JL; Ries RE; Huang BJ; Wang YC; Alonzo TA; Tian L; Mulder HL; Shaw TI; Ma J; Walsh MP; Song G; Westover T; Autry RJ; Gout AM; Wheeler DA; Wan S; Wu G; Yang JJ; Evans WE; Loh M; Easton J; Zhang J; Klco JM; Meshinchi S; Brown PA; Pruett-Miller SM; Ma X
Nat Commun; 2023 Apr; 14(1):1739. PubMed ID: 37019972
[TBL] [Abstract] [Full Text] [Related]
9. Pathologic, cytogenetic, and molecular features of acute myeloid leukemia with megakaryocytic differentiation: A report from the Children's Oncology Group.
Chisholm KM; Smith J; Heerema-McKenney AE; Choi JK; Ries RE; Hirsch BA; Raimondi SC; Wang YC; Dang A; Alonzo TA; Sung L; Aplenc R; Gamis AS; Meshinchi S; Kahwash SB
Pediatr Blood Cancer; 2023 May; 70(5):e30251. PubMed ID: 36789545
[TBL] [Abstract] [Full Text] [Related]
10. High caspase 3 and vulnerability to dual BCL2 family inhibition define eto2::GLIS2 pediatric leukemia.
Aid Z; Robert E; Lopez CK; Bourgoin M; Boudia F; Le Mene M; Riviere J; Baille M; Benbarche S; Renou L; Fagnan A; Thirant C; Federici L; Touchard L; Lecluse Y; Jetten A; Geoerger B; Lapillonne H; Solary E; Gaudry M; Meshinchi S; Pflumio F; Auberger P; Lobry C; Petit A; Jacquel A; Mercher T
Leukemia; 2023 Mar; 37(3):571-579. PubMed ID: 36585521
[TBL] [Abstract] [Full Text] [Related]
11. Identification of novel PIEZO1::cbfa2t3 and INO80C::SETBP1 fusion genes in an acute myeloid leukemia patient by RNA-seq.
Li Y; Liu Y; Gao X; Zhao W; Zhou F; Liu H; Wang W
Mol Biol Rep; 2023 Feb; 50(2):1961-1966. PubMed ID: 36472727
[TBL] [Abstract] [Full Text] [Related]
12. cbfa2t3-GLIS2 model of pediatric acute megakaryoblastic leukemia identifies FOLR1 as a CAR T cell target.
Le Q; Hadland B; Smith JL; Leonti A; Huang BJ; Ries R; Hylkema TA; Castro S; Tang TT; McKay CN; Perkins L; Pardo L; Sarthy J; Beckman AK; Williams R; Idemmili R; Furlan S; Ishida T; Call L; Srivastava S; Loeb AM; Milano F; Imren S; Morris SM; Pakiam F; Olson JM; Loken MR; Brodersen L; Riddell SR; Tarlock K; Bernstein ID; Loeb KR; Meshinchi S
J Clin Invest; 2022 Nov; 132(22):. PubMed ID: 36136600
[TBL] [Abstract] [Full Text] [Related]
13. Drug-Induced Liver Injury during Consolidation Therapy in Childhood Acute Lymphoblastic leukemia as Assessed for Causality Using the Updated RUCAM.
Qin FL; Sang GY; Zou XQ; Cheng DH
Can J Gastroenterol Hepatol; 2022; 2022():5914593. PubMed ID: 35369115
[TBL] [Abstract] [Full Text] [Related]
14. Exposure to magnetic fields and childhood leukemia: a systematic review and meta-analysis of case-control and cohort studies.
Brabant C; Geerinck A; Beaudart C; Tirelli E; Geuzaine C; Bruyère O
Rev Environ Health; 2023 Jun; 38(2):229-253. PubMed ID: 35302721
[TBL] [Abstract] [Full Text] [Related]
15. Acute megakaryoblastic leukemia with trisomy 3 and cbfa2t3::GLIS2: A case report.
Gillam J; Catic A; Paulraj P; Dalton J; Lai G; Jackson-Cook C; Turner S; Ferreira-Gonzalez A; Barrie E
Genes Chromosomes Cancer; 2022 Aug; 61(8):491-496. PubMed ID: 35294081
[TBL] [Abstract] [Full Text] [Related]
16. CTCF: A novel fusion partner of eto2 in a multiple relapsed acute myeloid leukemia patient.
Li J; Shen Z; Wang Z; Chao H; Xu Y; Zeng Z; Bian X; Zhang J; Pan J; Miao W; Wu W; Yao L; Chen S; Wen L
J Leukoc Biol; 2022 May; 111(5):981-987. PubMed ID: 34622967
[TBL] [Abstract] [Full Text] [Related]
17. [Allogeneic donor-derived CD19 CAR-T therapy of relapsed B-cell acute lmphoblastic leukemia after allogeneic hematopoietic stem cell transplantation].
Ma RZ; He Y; Yang DL; Wei JL; Pang AM; Jiang EL; Wang JX; Han MZ; Zhang RL; Feng SZ
Zhonghua Xue Ye Xue Za Zhi; 2021 May; 42(5):383-389. PubMed ID: 34218580
[No Abstract] [Full Text] [Related]
18. Healthcare resource utilization and economic burden of antifungal management in patients with hematologic malignancy in Japan: a retrospective database study.
Ueno R; Nishimura S; Fujimoto G; Ainiwaer D
Curr Med Res Opin; 2021 Jul; 37(7):1121-1134. PubMed ID: 33989102
[TBL] [Abstract] [Full Text] [Related]
19. Clinical impact of genomic characterization of 15 patients with acute megakaryoblastic leukemia-related malignancies.
Lalonde E; Rentas S; Wertheim G; Cao K; Surrey LF; Lin F; Zhao X; Obstfeld A; Aplenc R; Luo M; Li MM
Cold Spring Harb Mol Case Stud; 2021 Apr; 7(2):. PubMed ID: 33832921
[TBL] [Abstract] [Full Text] [Related]
20. CD56, HLA-DR, and CD45 recognize a subtype of childhood AML harboring cbfa2t3-GLIS2 fusion transcript.
Zangrando A; Cavagnero F; Scarparo P; Varotto E; Francescato S; Tregnago C; Cuccurullo R; Fagioli F; Nigro LL; Masetti R; Putti MC; Rizzari C; Santoro N; Pession A; Pigazzi M; Locatelli F; Basso G; Buldini B
Cytometry A; 2021 Aug; 99(8):844-850. PubMed ID: 33811445
[TBL] [Abstract] [Full Text] [Related]
[Next]
